HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hain Celestial ‘Natural’ Case Could Set Precedent Favorable To Industry

This article was originally published in The Rose Sheet

Executive Summary

Hain Celestial is not out of the woods regarding the truthfulness of its JASON natural claims, with a California appellate court reversing a lower court’s 2012 dismissal of a false-advertising class action against the firm. However, the appeals court agrees that FDA should have primary jurisdiction over natural cosmetics claims, which could result in the Hain case being stayed until the agency gets around to defining “natural” as it applies to cosmetics.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019450

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel